Idiopathic short stature
Idiopathic short stature | |
---|---|
Specialty | Endocrinology |
Diagnosis
Definition
In 2003
Other researchers have described a cutoff of 2.0 standard deviations.[4]
Treatment
There is some evidence that hormone treatment may not result in a significant improvement in psychosocial functioning.[5]
It is estimated that it would cost US$100,000 or more
[6]
to treat someone, but might only move them from the first percentile to perhaps the 10th. There is some ethical and economic concern whether such treatment would merely shift discrimination to the next most effected percentile.[
Advantage
Short stature decreases risk of venous insufficiency.[9]
See also
- Growth hormone treatment
References
- PMID 1105371.
- PMID 15240584.[permanent dead link]
- ^ "Idiopathic Short Stature: The FDA and Its High-Stakes Conceptual Quagmires". Michigan Technology Law Review. Michigan Technology Law Review. Retrieved 23 June 2021.
- PMID 16213173.
- PMID 16632673.
- PMID 16520445.
- PMID 17785695.
- PMID 17901908.
- ^ "Tall height".